Latest App Notes & Case Studies

Download this app note to discover a gut MPS that has physiologically relevant morphology, reduced barrier integrity and mucus expression. It can be used to predict drug permeability across an intestinal barrier.

Download this tech note to learn about absorbance and turbidimetric scattering measurements in photometry, along with using turbidimetric scattering assays in bacterial growth and endotoxin research.

Antibody–drug conjugates (ADCs) are monoclonal antibodies to which a cytotoxic small molecule drug is chemically linked. The structures of ADCs are more complex than their corresponding antibodies.

Moisture content determination is a vital measurement in the production and processing of most materials. Download this app note to discover how moisture testing can eliminate production issues, help you meet legal requirements and much more.

Antibodies are subject to instability issues due to chemical and physical instabilities and these effects can change the pharmacokinetics of the antibody. For this reason, produced antibodies must be thoroughly tested before they can be applied for treatment of patients.

Download this flyer to discover various monophosphoryl lipid A (MPLA) adjuvants as well as a trehalose dibehenate and DDA adjuvant system for tuberculosis vaccines.

Download this app note to discover an automated SARS-CoV-2 IgG Ab ELISA workflow that delivers stable assay performance across the entire plate and produces more than 1,000 results in 11 hours.

Antibody-based derivatives have received increased attention as therapeutics in biopharmaceutical development because of their unique capacity to engage multiple molecular targets, engage immune effector cells or even penetrate tissues previously inaccessible to conventional mAbs.

The SARS-CoV-2 spike protein has rightly garnered attention as a leading candidate for protein-based vaccines for COVID-19. Multiple studies have shown that neutralizing antibodies bind to the spike protein at both peptide and peptidoglycan epitopes.

The threat of global pandemics emphasises the quick identification of the cause of an emerging disease and its route of infection. Once these characteristics are defined, drug repurposing offers to identify previously approved drugs that might be applicable and quickly approvable for the treatment of the new disease.